	Exploring UK breastmilk donors' perspectives on breastfeeding as a protective factor against breast cancer: a qualitative study. BMJ Open D'Alessandro S, Griffin S, Weaver G, Flanagan JM, Brown A. PMID: 42810788 [PubMed - indexed for MEDLINE]
	Implementation of self-collected cervical screening in an under-screened, culturally and linguistically diverse antenatal population: a quality improvement study. BMJ Open Qual Wang M, Brand A, Plymoth M, Chen J, McGee T. PMID: 42810763 [PubMed - indexed for MEDLINE]
	Combined mastectomy and beating heart coronary artery bypass grafting: a single-session surgical approach. BMJ Case Rep Abbasoglu P, Gider V, Deniz E, Bas. PMID: 42810747 [PubMed - indexed for MEDLINE]
	Effectiveness of an exercise intervention on cognition in breast cancer survivors: a randomized controlled trial. J Natl Cancer Inst Hartman SJ, Shao LY, Zablocki RW, Natarajan L, Ahles T, Palmer BW, Sears DD, Tam RM, Mac V, Dillon L, Yan C, Parker BA. PMID: 42810736 [PubMed - as supplied by publisher]
	Exercise slows biological aging in breast cancer survivors: secondary analysis of a randomized trial. J Natl Cancer Inst Carlin D, Ott O, Sears DD, Ahles T, Desplats P, Hartman SJ. PMID: 42810733 [PubMed - as supplied by publisher]
	Abundance is not survival: intratumoural immune-cell fate as a missing endpoint in antibody-drug conjugate and checkpoint blockade combinations for triple-negative breast cancer. Crit Rev Oncol Hematol Dong Z, Zhao Y, Pei W, Liu Z, Sun L. PMID: 42810559 [PubMed - as supplied by publisher]
	Clinical Implications of the Type and Genomic Location of Pathogenic BRCA1 and BRCA2 Variants in Hereditary Breast and Ovarian Cancer. Crit Rev Oncol Hematol Zattarin E, Piombino C, Tenedini E, Siciliano F, Galasso I, Barbieri E, Grippa M, Zaniboni S, Ponzoni O, Mandó P, Lambertini M, Blondeaux E, Tagliafico E, Piacentini F, Yadav S, Grandi G, Dominici M, Cortesi L, Toss A. PMID: 42810557 [PubMed - as supplied by publisher]
	Total saponins from Paris polyphylla against breast cancer: an integrative pharmacological study combining chemical profiling, network pharmacology, machine learning, and in vitro validation. J Ethnopharmacol Huang HT, Zhou LP, Chen Q, Wang WQ, Yao SC, Zhang HJ, Li YX, Qu CH, Yin XB, Ni J, Dong XX. PMID: 42810458 [PubMed - as supplied by publisher]
	Tucatinib, trastuzumab, and capecitabine as second- or third-line therapy after trastuzumab deruxtecan in HER2-positive metastatic breast cancer: A multicenter retrospective study in France. Breast Frenel J, de Nonnevile A, Guerin-Charbonnel C, Zeghondy J, Mathiot L, Mailliez A, Poumeaud F, Isambert N, Arnedos M, Le Du F, Galland L, Kabirian R, Guiu S, Poestch L, Deluche E, Cherifi F, Dalenc F, Volant E, Pistilli B, San T, Bachelot T, Patsouris A, Bocquet F, Bailleux C, Loirat D, Larrouquere L. PMID: 42810229 [PubMed - as supplied by publisher]
	Analysis of outcomes of nab-paclitaxel compared to other taxanes in early breast cancer: A study revealing the critical role of calendar-time bias in real-world drug comparisons. Breast Xiao J, Huang M, Yan C, Wang Z, Wang T. PMID: 42810228 [PubMed - as supplied by publisher]
	Reflections on adjuvant pembrolizumab for triple-negative breast cancer treated with the KEYNOTE-522 regimen: Is it really necessary? Eur J Cancer Liutti VT, Wildiers H, Sonke GS, Neven P. PMID: 42810150 [PubMed - as supplied by publisher]
	A phase I, first-in-human dose-escalation and triple-negative breast cancer dose-expansion study of a TROP2-ADC F0024 (FDA018). Eur J Cancer Du Y, Meng Y, Liu X, Wang J, Wang Y, Wu F, Chen Y, Chen L, Qing L, Sun W, Liu K, Zhang J. PMID: 42810148 [PubMed - as supplied by publisher]
	Development of a europium-thiosemicarbazide-based nano-optical biosensor for early detection of HE4 in ovarian cancer. Spectrochim Acta A Mol Biomol Spectrosc Wanas A, Alshinnawy AS, Abdel Waled MM, Mohamed MR, Algethami FK, Attia MS, Abou-Omar MN. PMID: 42810034 [PubMed - as supplied by publisher]
	Assessing the Accuracy, Completeness, and Reference Quality of GPT-4 and Google for Gynecologic Cancer Information: Comparative Quantitative Study. JMIR Cancer Smick AH, Ayoola M, Rajpara R, Lazo I, Chase DM. PMID: 42809848 [PubMed - indexed for MEDLINE]
	Efficacy and safety of T-DXd versus Other HER2-targeted therapies in second-line and later settings for HER2-positive metastatic breast cancer: A Bayesian network meta-analysis. PLoS One Xiao Y, Fu J, Li J, Hu G. PMID: 42809558 [PubMed - indexed for MEDLINE]
	Efficacy and safety of immune checkpoint inhibitors combined with TKIs for recurrent or metastatic cervical cancer with PIK3CA mutation. PLoS One Chang L, Kang Y, Zhu M, Liu J, Lan C, Xu Q. PMID: 42809552 [PubMed - indexed for MEDLINE]
	Cytology of axillary breast carcinoma metastasis with squamous features - a morphological spectrum of diagnostically problematic aspirates. Acta Cytol Ng JKM, Cheung BHC, Cheung EKC, Tao LTS, Kwong A, Li J. PMID: 42809501 [PubMed - as supplied by publisher]
	Oncology Patients in Clinical Trials: A Health Care Cost Analysis. Am J Manag Care Ferro C, Fitch K, Bhatt PD, Ellenberg P, Bapat B, Gilligan AM, Moretz C, Dumanois RH. PMID: 42809499 [PubMed - indexed for MEDLINE]
	AMCP Market Insights: Managed care approaches to ESR1-mutated advanced breast cancer. J Manag Care Spec Pharm Flavin B, Tweed C, Evans J, Fleszar SL, Gandhi G, Hanna KS, Haumschild R, O'Shea T, Richardson T, Valbh T, Wolff D. PMID: 42809213 [PubMed - indexed for MEDLINE]
	Incidence and associated factors of medication-related osteonecrosis of the jaw in breast cancer patients with bone metastases: a nationwide registry study in Finland. Clin Oral Investig Kujanpää M, Vuollo V, Tiisanoja A, Laitala ML, Koivunen J, Sándor GK, Karki S. PMID: 42809145 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 335809

Page 1 of 16791



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy